204 related articles for article (PubMed ID: 30031811)
1. Exploring the potential of marine microbes in clinical management of Alzheimer's disease: A road map for bioprospecting and identifying promising isolates.
Muralidharan A; Josyula VR; Hariharapura RC
Life Sci; 2018 Sep; 208():149-160. PubMed ID: 30031811
[TBL] [Abstract][Full Text] [Related]
2. Bioactive secondary metabolites from marine microbes for drug discovery.
Nikapitiya C
Adv Food Nutr Res; 2012; 65():363-87. PubMed ID: 22361200
[TBL] [Abstract][Full Text] [Related]
3. Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential.
Kabir MT; Uddin MS; Jeandet P; Emran TB; Mitra S; Albadrani GM; Sayed AA; Abdel-Daim MM; Simal-Gandara J
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925063
[TBL] [Abstract][Full Text] [Related]
4. Marine microbial bioprospecting: Exploitation of marine biodiversity towards biotechnological applications-a review.
Hosseini H; Al-Jabri HM; Moheimani NR; Siddiqui SA; Saadaoui I
J Basic Microbiol; 2022 Sep; 62(9):1030-1043. PubMed ID: 35467037
[TBL] [Abstract][Full Text] [Related]
5. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
7. Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.
Llorach-Pares L; Nonell-Canals A; Sanchez-Martinez M; Avila C
Mar Drugs; 2017 Nov; 15(12):. PubMed ID: 29186912
[TBL] [Abstract][Full Text] [Related]
8. Exploitation of Marine Molecules to Manage Alzheimer's Disease.
Silva M; Seijas P; Otero P
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34203244
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
11. Marine microorganisms as a promising and sustainable source of bioactive molecules.
Romano G; Costantini M; Sansone C; Lauritano C; Ruocco N; Ianora A
Mar Environ Res; 2017 Jul; 128():58-69. PubMed ID: 27160988
[TBL] [Abstract][Full Text] [Related]
12. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
Repalli J; Meruelo D
Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
[TBL] [Abstract][Full Text] [Related]
13. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
14. Effects of Gelling Agent and Extracellular Signaling Molecules on the Culturability of Marine Bacteria.
Rygaard AM; Thøgersen MS; Nielsen KF; Gram L; Bentzon-Tilia M
Appl Environ Microbiol; 2017 May; 83(9):. PubMed ID: 28213548
[TBL] [Abstract][Full Text] [Related]
15. Marine bacterial extracts as a new rich source of drugs against Alzheimer's disease.
Zhu B; Li Z; Qian PY; Herrup K
J Neurochem; 2020 Feb; 152(4):493-508. PubMed ID: 31381155
[TBL] [Abstract][Full Text] [Related]
16. Anti-Alzheimer's Materials Isolated from Marine Bio-resources: A Review.
Rathnayake AU; Abuine R; Kim YJ; Byun HG
Curr Alzheimer Res; 2019; 16(10):895-906. PubMed ID: 31647396
[TBL] [Abstract][Full Text] [Related]
17. Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin.
Nicoletti R; Trincone A
Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26901206
[TBL] [Abstract][Full Text] [Related]
18. Marine Microalgae: Promising Source for New Bioactive Compounds.
de Vera CR; Díaz Crespín G; Hernández Daranas A; Montalvão Looga S; Lillsunde KE; Tammela P; Perälä M; Hongisto V; Virtanen J; Rischer H; Muller CD; Norte M; Fernández JJ; Souto ML
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30200664
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
20. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
Choi DY; Choi H
Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
